Three former Palantir AI execs founded Perceptic, which is getting funding from Accel, Air Street Capital, and Elder Gull.

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a ...

Add Yahoo as a preferred source to see more of our stories on Google. How would you feel if you knew your doctor was getting paid by big pharma? Would you still trust their medical advice? Every year, ...

Protect Our Care sponsors Lite-Brite demonstration outside of PhRMA’s headquarters calling for an end to drug company greed on Sept. 28, 2021 in Washington, DC. Addressing the nation during his State ...

The 340B Prescription Drug Anti-Discrimination Act protects one of the few tools we have that helps keep healthcare accessible and affordable in New York, at no cost to taxpayers.

Some of the best-selling drugs in the world are facing a loss of exclusivity in key jurisdictions in the upcoming years in what the sector calls "the patent cliff." The need for pharma to top up their ...

In 2013, I sat down at my computer and secured the URL t1international.com. I wanted a place where I could collect and share everything I was learning about the global insulin price crisis. I was only ...

More than 200 drugs in the pipeline for ALS are stuck in a system that favors big, slow-moving pharmaceutical companies.

Biotech dealmaking is on pace for a bumper year in 2026, with large drugmakers on an acquisition spree to boost their pipelines ahead of upcoming patent losses.

Big Pharma’s global machine has stocked American drug cabinets for decades. However, this year cracks in that setup have begun to appear — and are getting harder to ignore. These include fragile ...

There’s probably no industry more reviled in the age of populism than Big Pharma. Both political parties now engage in knee-jerk demonization of one of the most successful and valuable sectors of the ...

Drugs in this country cost too darn much. Trump knows it, Americans know it, and yet Big Pharma refuses to budge. Other countries impose price controls on prescription drugs, so manufacturers make up ...